Françoise Borson‐Chazot

<i>ARMC5</i>Mutations in Macronodular Adrenal Hyperplasia with Cushing's Syndrome

Guillaume Assié, Rossella Libé, Stéphanie Espiard et al. · New England Journal of Medicine · 2013 · 396 citations · Full text

Medicine, Endocrinology, Genetics +13

Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study

Adrian Daly, María A. Tichomirowa, Patrick Pétrossians et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 370 citations · Full text

Medicine, Endocrinology, Genetics +17

Risk Factors and Causes of Death in MEN1 Disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) Cohort Study Among 758 Patients

Pierre Goudet, Arnaud Murat, Christine Binquet et al. · World Journal of Surgery · 2009 · 341 citations

Medicine, Endocrinology, Clinical Epidemiology +9

⁹⁰Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide

David Bushnell, Thomas M. O’Dorisio, M. Sue O’Dorisio et al. · Journal of Clinical Oncology · 2010 · 304 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship.

Raffaella Barone, Françoise Borson‐Chazot, Roelf Valkema et al. · PubMed · 2005 · 292 citations · Full text

Pharmacy, Oncology, Pharmacology +17